1,011
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Full-thickness dermal wound regeneration using hypoxia preconditioned blood-derived growth factors: A case series

, , , , &
Article: 2234517 | Received 10 Feb 2023, Accepted 05 Jul 2023, Published online: 13 Jul 2023

References

  • Gurtner GC, Chapman MR. Regenerative medicine: charting a new course in wound healing. Adv Wound Care (New Rochelle). 2016;5(7):314–15. doi:10.1089/wound.2015.0663.
  • Owlarn S, Klenner F, Schmidt D, Rabert F, Tomasso A, Reuter H, Mulaw MA, Moritz S, Gentile L, Weidinger G, et al. Generic wound signals initiate regeneration in missing-tissue contexts. Nat Commun. 2017;8(1):2282. doi:10.1038/s41467-017-02338-x.
  • Veith AP, Henderson K, Spencer A, Sligar AD, Baker AB. Therapeutic strategies for enhancing angiogenesis in wound healing. Adv Drug Deliv Rev. 2019;146:97–125. doi:10.1016/j.addr.2018.09.010.
  • Dehkordi NA, Babaheydari MF, Chehelgerdi M, Dehkordi SR. Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies. Stem Cell Res Ther. 2019;10:111. doi:10.1186/s13287-019-1212-2.
  • Levin S. Principles of definitive soft tissue coverage with flaps. J Orthop Trauma. 2008;22(10 Suppl):161–66. doi:10.1097/BOT.0b013e318188e2ed.
  • Leypold T, Schäfer B, Boos AM, Beier JP. Plastic surgery reconstruction of chronic/non-healing wounds. Surg Technol Int. 2020;38:65–71. doi:10.52198/21.STI.38.WH1371.
  • Kozusko SD, Liu X, Riccio CA, Chang J, Boyd LC, Kokkalis Z, Konofaos P. Selecting a free flap for soft tissue coverage in lower extremity reconstruction. Injury. 2019;50(5):32–S39. doi:10.1016/j.injury.2019.10.045.
  • Moog P, Jensch M, Betzl J, Bauer A-T, Cerny MK, Schmauss D, Kükrek H, Erne H, Machens H-G, Megerle K, et al. Bacterial bioburden of wounds: influence of debridement and negative-pressure wound therapy (NPWT). J Wound Care. 2021;30(8):604–11. doi:10.12968/jowc.2021.30.8.604.
  • Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care (New Rochelle). 2015;4(9):560–82. doi:10.1089/wound.2015.0635.
  • Hadjipanayi E, Cheema U, Mudera V, Deng D, Liu W, Brown RA. First implantable device for hypoxia-mediated angiogenic induction. J Control Release. 2011;153(3):217–24. doi:10.1016/j.jconrel.2011.03.029.
  • Hadjipanayi E, Cheema U, Hopfner U, Bauer A, Machens HG, Schilling AF. Injectable system for spatio-temporally controlled delivery of hypoxia-induced angiogenic signalling. J Control Release. 2012;161(3):852–60. doi:10.1016/j.jconrel.2012.04.048.
  • Ishihara M, Kishimoto S, Takikawa M, Hattori H, Nakamura S, Shimizu M. Biomedical application of low molecular weight heparin/protamine nano/micro particles as cell- and growth factor-carriers and coating matrix. Int J Mol Sci. 2015;16(12):11785–803. doi:10.3390/ijms160511785.
  • Tomblyn S, Pettit, kneller EL., Walker, SJ, Ellenburg, MD, Kowalczewski, CJ, Van Dyke, M, Burnett, L, Saul, JM, et al. Keratin hydrogel carrier system for simultaneous delivery of exogenous growth factors and muscle progenitor cells. J Biomed Mater Res B Appl Biomater. 2016;104(5):864–79. doi:10.1002/jbm.b.33438.
  • Alarçin E, Lee TY, Karuthedom S, Mohammadi M, Brennan MA, Lee DH, Marrella A, Zhang J, Syla D, Zhang YS, et al. Injectable shear-thinning hydrogels for delivering osteogenic and angiogenic cells and growth factors. Biomater Sci. 2018;6(6):1604–15. doi:10.1039/C8BM00293B.
  • Sorrell JM, Caplan A. Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther. 2010;1(4):30. doi:10.1186/scrt30.
  • Hassan WU, Greiser U, Wang W. Role of adipose-derived stem cells in wound healing. Wound Repair Regen. 2014;22(3):313–25. doi:10.1111/wrr.12173.
  • Maranda EL, Rodriguez-Menocal L, Badiavas EV. Role of mesenchymal stem cells in dermal repair in burns and diabetic wounds. Curr Stem Cell Res Ther. 2017;12(1):61–70. doi:10.2174/1574888X11666160714115926.
  • Laschke MW, Menger MD. The simpler, the better: tissue vascularization using the body’s own resources. Trends Biotechnol. 2022;40(3):281–90. doi:10.1016/j.tibtech.2021.07.002.
  • Chicharro-Alcántara D, Rubio-Zaragoza M, Damiá-Giménez E, Carrillo-Poveda J, Cuervo-Serrato B, Peláez-Gorrea P, Sopena-Juncosa J. Platelet rich plasma: new insights for cutaneous wound healing management. J Funct Biomater. 2018;9(1):10. doi:10.3390/jfb9010010.
  • Carter MJ, Fylling CP, Parnell LK. Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty. 2011;11:38.
  • Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794. doi:10.3390/ijms21207794.
  • Marx RE. Platelet- Rich Plasma (Prp): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225–28. doi:10.1097/00008505-200110000-00002.
  • Sclafani AP. Applications of platelet-rich fibrin matrix in facial plastic surgery. Facial Plast Surg. 2009;25(4):270–76. doi:10.1055/s-0029-1242033.
  • Van Den Dolder J, Mooren R, Vloon APG, Stoelinga PJW, Jansen JA. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng. 2006;12(11):3067–73. doi:10.1089/ten.2006.12.3067.
  • Aghaloo TL, Moy P, Freymiller DEG. Investigation of platelet-rich plasma in rabbit cranial defects: a pilot study. Oral Maxillofac Surg. 2002;60(10):1176–81. doi:10.1053/joms.2002.34994.
  • Hadjipanayi E, Kuhn P-H, Moog P, Bauer A-T, Kuekrek H, Mirzoyan L, Hummel A, Kirchhoff K, Salgin B, Isenburg S, et al. The fibrin matrix regulates angiogenic responses within the hemostatic microenvironment through biochemical control. PLoS One. 2015;10(8):1–20. doi:10.1371/journal.pone.0135618.
  • Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, Expósito JA, Bolíbar I, Rodríguez L, Garcia J, Zaror C. Autologous platelet-rich plasma for treating chronic wounds. AR Cochrane Database Syst Rev. 2016;25(5):1–56. doi:10.1002/14651858.CD006899.pub3.
  • Moog P, Schams R, Schneidinger A, Schilling AF, Machens H-G, Hadjipanayi E, Dornseifer U. Effect of hypoxia preconditioned secretomes on lymphangiogenic and angiogenic sprouting: an in vitro analysis. Biomedicines. 2020;8(9):365. doi:10.3390/biomedicines8090365.
  • Moog P, Kirchhoff K, Bekeran S, Bauer A-T, von Isenburg S, Dornseifer U, Machens H-G, Schilling AF, Hadjipanayi E. Comparative evaluation of the angiogenic potential of hypoxia preconditioned blood-derived secretomes and platelet-Rich Plasma: an in vitro analysis. Biomedicines. 2020;8(1):16. doi:10.3390/biomedicines8010016.
  • Melchinger H, Jain K, Tyagi T, Hwa J. Role of platelet mitochondria: life in a nucleus-free zone. Front Cardiovasc Med. 2019;29(6):153. doi:10.3389/fcvm.2019.00153.
  • Wilkinson HN, Hardman M. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020;10(9):200–23. doi:10.1098/rsob.200223.
  • Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res. 2012;49(1):35–43. doi:10.1159/000339613.
  • Hadjipanayi E, Schilling AF. Regeneration through autologous hypoxia preconditioned plasma. Organogenesis. 2014;10(2):164–69. doi:10.4161/org.29208.
  • Hadjipanayi H, Bekeran S, Moog P. Extracorporeal wound simulation as a foundation for tissue repair und regeneration therapies. Int J Transplant & Plastic Surg. 2016;2:1–10.
  • Hadjipanayi E, Brown RA, Mudera V, Deng D, Liu W, Cheema U. Controlling physiological angiogenesis by hypoxia-induced signaling. J Control Release. 2010;146(3):309–17. doi:10.1016/j.jconrel.2010.05.037.
  • Hadjipanayi E, Bauer AT, Moog P, Salgin B, Kuekrek H, Fersch B, Hopfner U, Meissner T, Schlüter A, Ninkovic M, et al. Cell-free carrier system for localised delivery of peripheral blood cell-derived engineered factor signaling: towards development of a one-step device for autologous angiogenic therapy. J Control Release. 2013;169(1–2):91–102. doi:10.1016/j.jconrel.2013.04.008.
  • Hadjipanayi E, Moog P, Bekeran S, Kirchhoff K, Berezhnoi A, Aguirre J, Bauer A-T, Kükrek H, Schmauss D, Hopfner U, et al. In vitro characterization of Hypoxia Preconditioned Serum (HPS)—fibrin hydrogels: basis for an injectable biomimetic tissue regeneration therapy. J Funct Biomater. 2019;10(2):1–28. doi:10.3390/jfb10020022.
  • Jiang J, Röper L, Alageel S, Dornseifer U, Schilling AF, Hadjipanayi E, Machens H-G, Moog P. Hypoxia Preconditioned Serum (HPS) promotes osteoblast proliferation, migration and matrix deposition. Biomedicines. 2022;10(7):1631. doi:10.3390/biomedicines10071631.
  • Jiang J, Kraneburg U, Dornseifer U, Schilling AF, Hadjipanayi E, Machens H-G, Moog P. Hypoxia Preconditioned Serum (HPS)-hydrogel can accelerate dermal wound healing in mice—an in vivo pilot study. Biomedicines. 2022;10:176. doi:10.3390/biomedicines10010176.
  • Moog P, Jensch M, Hughes J, Salgin B, Dornseifer U, Machens H-G, Schilling AF, Hadjipanayi E. Use of oral anticoagulation and diabetes do not inhibit the angiogenic potential of hypoxia preconditioned blood-derived secretomes. Biomedicines. 2020;8(8):283. doi:10.3390/biomedicines8080283.
  • Rinker B. The evils of nicotine: an evidence-based guide to smoking and plastic surgery. Ann Plast Surg. 2013;70(5):599–605. doi:10.1097/SAP.0b013e3182764fcd.
  • Xu Z, Norwich-Cavanaugh A, Hsia HC. Can nicotine replacement therapy decrease complications in plastic surgery? Ann Plast Surg. 2019;83(1 Suppl):55–58. doi:10.1097/SAP.0000000000002095.
  • Monstrey S, Middelkoop E, Vranckx JJ, Bassetto F, Ziegler UE, Meaume S, Téot L. Updated scar management practical guidelines: noninvasive and invasive measures. J Plast Reconstr Aesthet Surg. 2014;67(8):1017–25. doi:10.1016/j.bjps.2014.04.011.
  • Lipman K, Wang M, Berthiaume E, Holloway J, Da Lio A, Ting K, Soo C, Zheng Z. Evaluating current scar assessment methods. Ann Plast Surg. 2020;84(2):222–31. doi:10.1097/SAP.0000000000002029.
  • Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg. 2022;149(1):79–94. doi:10.1097/PRS.0000000000008667.
  • Le Louarn C, Pascal JF. The high-superior-tension technique: evolution of lipoabdominoplasty. Aesthetic Plast Surg. 2010;34(6):773–81. doi:10.1007/s00266-010-9551-5.
  • Pascal JF, Le Louarn C. Remodeling bodylift with high lateral tension. Aesthetic Plast Surg. 2002;26(3):223–30. doi:10.1007/s00266-002-1478-z.
  • Serra MP, Longhi P, Sinha M. Breast reduction with a superomedial pedicle and a vertical scar (Hall-Findlay’s technique): experience with 210 consecutive patients. Ann Plast Surg. 2010;64(3):275–78. doi:10.1097/SAP.0b013e3181b0a611.
  • Ehrl DC, Heidekrueger PI, Broer PN. Pyoderma gangrenosum after breast surgery: a systematic review. J Plast Reconstr Aesthet Surg. 2018;71(7):1023–32. doi:10.1016/j.bjps.2018.03.013.
  • Simon AM, Khuthailia D, Hammond DC, Andres A. Pyoderma gangrenosum following reduction mammaplasty. Can J Plast Surg. 2006;14(1):37–40. doi:10.1177/229255030601400109.
  • Doren EL, Aya-Ay M. Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids. Aesthet Surg J. 2014;34(3):394–99. doi:10.1177/1090820X13520448.
  • Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314–21. doi:10.1038/nature07039.
  • Kirloskar KM, Dekker PK, Kiene J, Zhou S, Bekeny JC, Rogers A, Zolper EG, Fan KL, Evans KK, Benedict CD, et al. The relationship between autoimmune disease and disease-modifying antirheumatic drugs on wound healing. Adv Wound Care (New Rochelle). 2022;11(12):650–56. doi:10.1089/wound.2021.0150.
  • Zheng YL, Wang WD, Li MM, Lin S, Lin HL. Updated role of neuropeptide Y in nicotine-induced endothelial dysfunction and atherosclerosis. Front Cardiovasc Med. 2021;23(8):630968. doi:10.3389/fcvm.2021.630968.
  • Lutz DA, Hallock GG. Microsurgical transfer of vascularized tissue to close problem wounds. Aorn J. 1995;62(2):234-238, 240, 242–233. doi:10.1016/S0001-2092(06)63655-7.
  • Kozak GM HJ, RB B, Broach RB, Shakir S, Calvert C, Stranix JT, Messa C, Levin LS, Serletti JM, Kovach SJ, et al. Comparative effectiveness analysis of complex lower extremity reconstruction: outcomes and costs for biologically based, local tissue rearrangement, and free flap reconstruction. Plast Reconstr Surg. 2020;145(3):608–16. doi:10.1097/PRS.0000000000006589.
  • Johnson PE, Kerahan D, Bauer BS. Dermal and epidermal response to soft-tissue expansion in the pig. Plast Reconstr Surg. 1998;81(3);390–97.
  • He J, Shan S, Li Q, Fang B, Xie Y. Mechanical stretch triggers epithelial-mesenchymal transition in keratinocytes through piezo1 channel. Front Physiol. 2022;13:745572. doi:10.3389/fphys.2022.745572.
  • Hadjipanayi E, Schilling AF. Hypoxia- based strategies for angiogenic induction. Organogenesis Landes Bioscience. 2013;9(4):1–12. doi:10.4161/org.25970.
  • Pappalardo V, Frattini F, Ardita V, Rausei S. Negative Pressure Therapy (NPWT) for management of surgical wounds: effects on wound healing and analysis of devices evolution. Surg Technol Int. 2019;34:56–67.
  • Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–75. doi:10.1038/nmeth.2089.